• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CareXM adds Home-Based Care Industry Leader, Carla Davis, to its Board of Directors

    5/7/25 8:46:00 AM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email

    CareXM, the leading provider of clinical triage and virtual care coordination solutions for post-acute care, announced today that Carla Davis has been appointed as an independent member of its Board of Directors, effective May 6, 2025. Davis joins the Board following an impressive 30-year career in home health and hospice, serving most recently as Senior Vice President of Hospice Operations at LHC Group.

    "We are excited to welcome Carla to CareXM's Board of Directors," said Si Luo, chief executive officer at CareXM. "Carla was one of the first customer leaders I had the privilege of meeting after joining CareXM, and from our first conversation, her unwavering commitment to advancing the patient and caregiver experience in hospice and home-based care settings at large was evident. Having her compassion, vision, and perspective on our board represents a significant opportunity to guide the company in its rapid growth and evolution to become the most reliable triage solution partner for home-based care organizations. I'm confident that her expertise and influence will play a pivotal role in shaping our future."

    "After decades in home-based care, I've seen how critical after-hours triage and patient care coordination are to both the patient experience and the experience of care teams. What excites me most about joining the Board at this moment is CareXM's experience in supporting our industry's rapid consolidation and growth. That experience is meeting a moment of technological breakthrough in pragmatic application of AI that stands to create real impact on reducing the pressure triage and visit nurses face. I look forward to joining the board during this exciting moment and working together with the management team to advance the experience of patients, families, and staff throughout the advanced illness journey," said Carla Davis, newly appointed board member.

    About Carla Davis

    Carla Davis is an experienced industry advocate and executive leader with an extensive background in hospice, palliative care, and home health. Davis most recently served as Senior Vice President of Hospice and Palliative Care Operations and Business Development for LHC Group, a national provider of in-home healthcare services and a division of UnitedHealth Group (NYSE:UNH).

    Prior to LHC Group, Davis held a variety of executive roles across multi-service line care organizations, including Chief Executive Officer of Heart of Hospice, Chief Operating Officer of VistaCare, and Vice President of Sales, Marketing, and Market Development at Heartland Home Health Care and Hospice, a division of HCR ManorCare. She has a strong background in compliance, including experience with one of the country's largest Medicare Administrative Contractors, Palmetto GBA.

    Davis has a passion for increasing access to high-quality care and has played a leading role in transforming end-of-life care across the country through her operational and growth expertise.

    She has served on the boards of the National Hospice and Palliative Care Organization, Hospice Action Network, Home Care 100, and as President of the Louisiana and Mississippi Alliance for the Advancement of End-of-Life Care.

    About CareXM

    As the leader in nursing triage and virtual care coordination, CareXM sets the standard for exceptional patient and provider experiences. Trusted by 4,500+ provider organizations, CareXM offers the most reliable path to fully resolving patient needs through efficient, accurate triage and proactive patient engagement solutions that help post-acute provider organizations scale with operating leverage without sacrifices to quality. To learn more, visit carexm.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250507839349/en/

    Drew Casteel

    [email protected]

    Get the next $UNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    6/11/2025$312.00Outperform → Neutral
    Robert W. Baird
    5/21/2025$270.00Hold → Reduce
    HSBC Securities
    5/19/2025$308.00Buy → Hold
    TD Cowen
    5/14/2025Strong Buy → Mkt Perform
    Raymond James
    5/14/2025$350.00Buy → Neutral
    BofA Securities
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    4/21/2025Buy → Hold
    Argus
    1/10/2025$595.00Hold → Buy
    HSBC Securities
    More analyst ratings

    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries

      AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companie

      6/4/25 3:50:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions

      UnitedHealth Group (NYSE:UNH) provided updates on its 2025 annual shareholder meeting and actions taken by its Board of Directors. Shareholders re-elected all current directors: Charles Baker, Timothy Flynn, Paul Garcia, Kristen Gil, Stephen Hemsley, Michele Hooper, F. William McNabb III, Valerie Montgomery Rice, M.D. and John Noseworthy, M.D. Shareholders also: Approved the advisory resolution on the Company's executive compensation. Ratified Deloitte & Touche LLP as the Company's independent registered public accounting firm. Voted against the shareholder proposal requesting a shareholder vote regarding excessive golden parachutes. At its regular quarterly meeting, the Boa

      6/4/25 6:50:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Announces Earnings Release Date

      UnitedHealth Group (NYSE:UNH) will release its second quarter 2025 financial results on Tuesday, July 29, 2025, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investor Relations page of the company's website (www.unitedhealthgroup.com). The replay will be available through August 12 on the website. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by te

      6/2/25 4:15:00 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:47 PM ET
      $UNH
      Medical Specialities
      Health Care
    • CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:45 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Flynn Timothy Patrick bought $491,786 worth of shares (1,533 units at $320.80) (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 12:28:22 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    SEC Filings

    See more
    • SEC Form 424B5 filed by UnitedHealth Group Incorporated

      424B5 - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      6/18/25 5:00:15 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form FWP filed by UnitedHealth Group Incorporated

      FWP - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      6/17/25 5:23:28 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form 424B5 filed by UnitedHealth Group Incorporated

      424B5 - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      6/17/25 8:45:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/13/24 5:16:09 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/24 10:05:20 AM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/23 12:39:51 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UnitedHealth downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded UnitedHealth from Outperform to Neutral and set a new price target of $312.00

      6/11/25 7:46:38 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded UnitedHealth from Hold to Reduce and set a new price target of $270.00

      5/21/25 8:41:18 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by TD Cowen with a new price target

      TD Cowen downgraded UnitedHealth from Buy to Hold and set a new price target of $308.00

      5/19/25 8:51:13 AM ET
      $UNH
      Medical Specialities
      Health Care